SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Vascular and Endovascular Surgery
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gecim, I. E.
Right arrow Articles by Sells, R. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gecim, I. E.
Right arrow Articles by Sells, R. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Preliminary Experience with the Human Homologous Vein Graft for Vascular Access

I. E. Gecim, M.D.

Department of General Surgery, Ankara University, Faculty of Medicine Hospitals, Ankara, Türkiye

R. G. Ward, F.R.C.S.

A. Bakran, F.R.C.S.

A. Aikawa, M.D.

R. A. Sells, F.R.C.S.

Department of Transplant Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom

In a preliminary study, 38 preserved human homologous saphenous vein grafts were used for secondary vascular access in 36 chronic hemodialysis patients. Cumulative oneyear patency was 67%. Twelve grafts failed, 10 owing to thrombosis and 2 owing to infection. Overall complication rate, morbidity, and patency were compatible with the other available graft materials. A prospective randomized trial of Varivas graft against PTFE has been instigated.

Vascular and Endovascular Surgery, Vol. 30, No. 5, 395-398 (1996)
DOI: 10.1177/153857449603000510
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement